Skin Elements Limited (ASX:SKN)

Skin Elements Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	0.47	0.42	0.19	1.41	0.29
Revenue Growth (YoY)	12.92%	114.39%	-86.22%	387.75%	-32.09%
Cost of Revenue	0.06	0.05	0.1	0.37	0.1
Gross Profit	0.41	0.36	0.1	1.04	0.19
Selling, General & Admin	1.49	0.9	2.09	2.06	2.04
Research & Development	1.19	2.49	1.69	2.02	2.24
Other Operating Expenses	-0.64	-1.19	-1.18	-1.48	-1.05
Operating Expenses	2.04	2.44	3.13	2.61	3.24
Operating Income	-1.64	-2.08	-3.03	-1.57	-3.05
Interest Expense	-0.09	-0.08	-0.06	-0.01	-0.09
Interest & Investment Income	0	0	0	-	-
Other Non Operating Income (Expenses)	-	-	-0.84	-	-
EBT Excluding Unusual Items	-1.73	-2.16	-3.93	-1.58	-3.14
Asset Writedown	-	-	-7.49	-	-
Other Unusual Items	-	-	-	-	0.09
Pretax Income	-1.73	-2.16	-11.42	-1.58	-3.04
Net Income	-1.73	-2.16	-11.42	-1.58	-3.04
Net Income to Common	-1.73	-2.16	-11.42	-1.58	-3.04
Shares Outstanding (Basic)	787	557	437	400	351
Shares Outstanding (Diluted)	787	557	437	400	351
Shares Change (YoY)	41.29%	27.51%	9.28%	13.89%	56.94%
EPS (Basic)	-0.00	-0.00	-0.03	-0.00	-0.01
EPS (Diluted)	-0.00	-0.00	-0.03	-0.00	-0.01
Gross Margin	86.45%	86.95%	49.00%	74.07%	65.95%
Operating Margin	-348.09%	-500.47%	-1561.07%	-111.31%	-1054.89%
Profit Margin	-367.79%	-519.29%	-5880.65%	-112.25%	-1053.72%
EBITDA	-1.63	-2.08	-2.64	-1.17	-2.65
EBITDA Margin	-	-	-	-83.25%	-
D&A For EBITDA	0.01	0.01	0.4	0.4	0.39
EBIT	-1.64	-2.08	-3.03	-1.57	-3.05
EBIT Margin	-	-	-	-111.31%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.